Keren Paz

Company: Nectin Therapeutics

Job title: Chief Development Officer

Seminars:

SWOT Analysis Panel Discussion: 9:00 am

• What happened in the SKYSCRAPER trial? • Progress, momentum and advancements one year on • What are the strengths of existing TIGIT axis targeted therapies that continue to drive development? • What is the market opportunity versus unmet patient clinical need that TIGIT axis targeted approaches can address? • How can we overcome the…Read more

day: Day One